Astellas Pharma: Astellas Receives Approval from the EC for VYLOY in Combination with Chemotherapy for Advanced Gastric and Gastroesophageal Junction Cancer

JPX · Sep 24 09:30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.